Semaglutide shots near me: how the UK system actually works

What the STEP 1 trial data tells you before you book anything

Wegovy's weight-management evidence starts with the STEP 1 study: 68 weeks, 2.4mg weekly semaglutide, and an average body-weight reduction of roughly 15%, figures published in the STEP 1 paper in the New England Journal of Medicine. That's a meaningful number, and if you want to understand what the treatment actually involves before committing, our guide to semaglutide shots covers the practicalities in plain terms. What the headline figure doesn't always tell you is that the result came alongside a reduced-calorie diet and increased physical activity in the trial, and that participants were titrated slowly through the dosing schedule over roughly five months before reaching 2.4mg maintenance.

The MHRA approved a higher-dose 7.2mg pen in April 2026, with trials reporting around 20.7% average weight reduction at 72 weeks. That narrows the gap with tirzepatide results considerably. Whether that dose is right for a specific person is a clinical question, not a decision to make from a search results page. Our guide to Wegovy injections walks through the full dosing pathway if you want the detail.

One practical routine note: the pen lives in the fridge between doses, keep it on the door shelf where it's visible, and you're less likely to miss a weekly injection. For the exact room-temperature window if you travel, the SmPC is the definitive reference; the Patient Information Leaflet that comes with the pen spells it out clearly.

Why 'near me' is the wrong filter for semaglutide in 2025–2026

The instinct to search locally makes sense for a lot of healthcare. For semaglutide it's largely a red herring. NICE's appraisal of Wegovy (TA875) recommends it only within specialist weight management services on the NHS, where waiting times in many areas run to months or longer. Private GP clinics that offer semaglutide in person add consultation fees, repeat appointment costs, and often require you to collect or arrange your own supply.

A GPhC-registered online pharmacy changes the geography entirely. The prescription is issued by a real, named prescriber after reviewing your consultation, a person reads your answers, not software. If clinically suitable, the pen ships the same day (for orders placed before noon, Monday to Friday) and arrives free the next working day via tracked DPD delivery. You can verify any online pharmacy on the GPhC pharmacy register before handing over any personal or payment details. That check takes under a minute and is the most important step in this process.

The wider question of finding semaglutide near you covers both NHS and private routes in full, including what to look for in any provider.

Who the licence actually covers, and what disqualifies you

Wegovy is licensed for adults with a BMI of 30 or above, or 27 or above alongside at least one weight-related condition such as high blood pressure, raised cholesterol, or type 2 diabetes. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. BMI alone doesn't guarantee approval, a prescriber reviews the whole clinical picture, including any medicines you're already taking.

There are situations where semaglutide is not suitable. Pregnancy, breastfeeding, or actively trying to conceive are all contraindications; the guidance is to stop treatment well before conception. It isn't licensed for under-18s. A personal or family history of medullary thyroid carcinoma or MEN2 requires prescriber discussion, as do certain gastrointestinal conditions. If you're wondering specifically how Wegovy interacts with blood sugar, that page explains the evidence clearly.

For an overview of what's available and how the eligibility process works, our weight-loss treatments overview is a good starting point.

The counterfeit risk, and how to stay on the right side of it

Demand for semaglutide shots has produced a counterfeit market that the MHRA has actively pursued since 2023. Fake pens have contained insulin rather than semaglutide; some led to hospitalisations. In 2025 alone, roughly 20 million doses of illegally traded weight-loss medicines (around £45m street value) were seized, and the MHRA uncovered a UK site manufacturing counterfeit tirzepatide pens. The pattern is consistent: sellers offering these medicines without a valid prescription, via social media or unverified websites, at prices well below the market rate.

A discount code for a prescription medicine is a red flag, not a saving. The MHRA's guidance on reporting suspect sellers via Yellow Card is straightforward to use. If you do encounter a suspicious listing, reporting it takes a couple of minutes. Our frequently asked questions include guidance on spotting legitimate providers. For a closer look at what private Wegovy costs through a regulated pharmacy (and what any quoted price should include) the Wegovy cost page sets out the full picture.

When you're ready to find out whether you're clinically suitable, start your free consultation with our prescribers.